 |
|

1993 - Constitution of the Group
Aim:
“To promote the development of specific programs for the study and the research in the field of intensification chemotherapy in oncology

1995 - Constitution of the Association

1999 - Strategic change
Fields of action and priorities:
Treatment with high doses of QT for solid tumours (essentially in breast cancer).
Other experimental treatments.

2002 - Strategic change
To participate in multinational Clinical Trials

2008 - Strategic change
Strategic Plan at 5 years:
To participate in innovators clinical trials and translational research.
|
|
|
|
 |